Cellular hierarchies predict drug response in acute myeloid leukemia

In a recent Nature Medicine study, Zeng and colleagues integrate both genomic and stem cell models of acute myeloid leukemia (AML) by deconvoluting cellular hierarchies of more than 1,000 AML samples. This work introduces a framework capable of predicting drug responses to targeted therapies in futu...

Full description

Saved in:
Bibliographic Details
Main Authors: Raffel, Simon (Author) , Velten, Lars (Author) , Haas, Simon (Author)
Format: Article (Journal)
Language:English
Published: September 12, 2022
In: Cancer cell
Year: 2022, Volume: 40, Issue: 9, Pages: 917-919
ISSN:1878-3686
DOI:10.1016/j.ccell.2022.08.019
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ccell.2022.08.019
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S153561082200383X
Get full text
Author Notes:Simon Raffel, Lars Velten, and Simon Haas
Description
Summary:In a recent Nature Medicine study, Zeng and colleagues integrate both genomic and stem cell models of acute myeloid leukemia (AML) by deconvoluting cellular hierarchies of more than 1,000 AML samples. This work introduces a framework capable of predicting drug responses to targeted therapies in future clinical trials.
Item Description:Gesehen am 07.02.2023
Physical Description:Online Resource
ISSN:1878-3686
DOI:10.1016/j.ccell.2022.08.019